Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Insys Therapeutics Inc (INSY)

Insys Therapeutics Inc (INSY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,707
  • Shares Outstanding, K 74,569
  • Annual Sales, $ 82,080 K
  • Annual Income, $ -124,510 K
  • 60-Month Beta 3.21
  • Price/Sales 0.27
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.74
  • Most Recent Earnings -0.55 on 05/13/19
  • Next Earnings Date 05/14/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +270,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.14 +105.00%
on 06/11/19
1.90 -84.68%
on 06/06/19
-0.77 (-72.54%)
since 05/17/19
3-Month
0.14 +105.00%
on 06/11/19
4.97 -94.14%
on 04/09/19
-4.10 (-93.37%)
since 03/18/19
52-Week
0.14 +105.00%
on 06/11/19
11.65 -97.50%
on 08/30/18
-7.47 (-96.25%)
since 06/18/18

Most Recent Stories

More News
Medical Marijuana Market Growth and Top Key Players Analysis Report 2026

APHA : 3.92 (-5.31%)
ACB.TO : 2.08 (-5.88%)
CBDS : 1.1500 (-3.36%)
INSY : 0.29 (unch)
MEDFF : 18.8100 (-0.37%)
12.4%+ growth for Medical Cannabis Market Size to reach 21150 million USD by 2025

The report is a comprehensive exploration of Global Medical Cannabis market offering growth rates, size of the industry, competitive landscape information, factors to the contributing growth of the global...

APHA : 3.92 (-5.31%)
ACB.TO : 2.08 (-5.88%)
INSY : 0.29 (unch)
MJNA : 0.0185 (-2.12%)
Global Medical Marijuana Market 2020-2029| Medical Marijuana Inc, GW Pharmaceuticals plc and MedReleaf Corp

Global Medical Marijuana Market (Revenue and Volume), Type, Application, End-User, and Regional Analysis, Import-Export Analysis, Industry Analysis, Premium Insights, Intellectual Property Analysis, Market...

APHA : 3.92 (-5.31%)
ACB.TO : 2.08 (-5.88%)
CBDS : 1.1500 (-3.36%)
INSY : 0.29 (unch)
MJNA : 0.0185 (-2.12%)
Medical Cannabis Market Global Competitive Insights and Outlook 2020

published by explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market,...

APHA : 3.92 (-5.31%)
ACB.TO : 2.08 (-5.88%)
INSY : 0.29 (unch)
MJNA : 0.0185 (-2.12%)
Medical Marijuana Market Challenges, Key Players, Market Segments, Development, Opportunities, Forecast Report 2026

The report titled, has been recently published by The Medical Marijuana market has been garnering remarkable momentum in recent years. Demand continues to rise due to increasing purchasing power is projected...

APHA : 3.92 (-5.31%)
ACB.TO : 2.08 (-5.88%)
CBDS : 1.1500 (-3.36%)
INSY : 0.29 (unch)
MEDFF : 18.8100 (-0.37%)
Medical Cannabis Market 2019 Disclosing Latest Trends and Advancement Outlook 2025

The recently Published Global Market research study with more than 100 industry informative desk and Figures spread through Pages and easy to understand detailed TOC on "Medical Cannabis Market".The report...

APHA : 3.92 (-5.31%)
ACB.TO : 2.08 (-5.88%)
INSY : 0.29 (unch)
MJNA : 0.0185 (-2.12%)
Medical Marijuana Market Booming by Size, Trends and Top Growing Companies- Aurora Cannabis Medical Marijuana, Green Relief Cannabis Sativa, Insys Therapeutics, The Peace Naturals Project,

ACB.TO : 2.08 (-5.88%)
CBDS : 1.1500 (-3.36%)
INSY : 0.29 (unch)
Medical Cannabis Market Global Insights, Trends and Huge Business Opportunities 2019 to 2024

(MENAFN - Ameliorate Solutions)

APHA : 3.92 (-5.31%)
ACB.TO : 2.08 (-5.88%)
CBDS : 1.1500 (-3.36%)
CMMDF : 20.9880 (-7.13%)
INSY : 0.29 (unch)
MJNA : 0.0185 (-2.12%)
MEDFF : 18.8100 (-0.37%)
Medical Cannabis Market Global Insights, Trends and Huge Business Opportunities 2019 to 2024

APHA : 3.92 (-5.31%)
ACB.TO : 2.08 (-5.88%)
CBDS : 1.1500 (-3.36%)
CMMDF : 20.9880 (-7.13%)
INSY : 0.29 (unch)
MJNA : 0.0185 (-2.12%)
MEDFF : 18.8100 (-0.37%)
Medical Cannabis Market Size | Highest Growth Rate of 24.4% CAGR will generate 20200 million US$ by the end of 2025

Market Study Report, LLC, has added a research study on ‘Medical Cannabis market’ which offers a concise summary regarding market valuation, market share, regional spectrum, revenue estimation and...

ACB.TO : 2.08 (-5.88%)
INSY : 0.29 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade INSY with:

Business Summary

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and...

See More

Key Turning Points

2nd Resistance Point 0.44
1st Resistance Point 0.36
Last Price 0.29
1st Support Level 0.24
2nd Support Level 0.18

See More

52-Week High 11.65
Fibonacci 61.8% 7.25
Fibonacci 50% 5.90
Fibonacci 38.2% 4.54
Last Price 0.29
52-Week Low 0.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar